FebriDx host response point-of-care testing improves patient triage for coronavirus disease 2019 (COVID-19) in the emergency department.

Christopher T MansbridgeAlex R TannerKate R BeardFlorina BorcaHang T T PhanNathan J BrendishStephen PooleChristopher HillMichael Kiuber Robert CrouchDaniel WaddingtonTristan W Clark

Published in: Infection control and hospital epidemiology (2022)

FebriDx improved the triage of patients with suspected COVID-19 and reduced the time that severe acute respiratory coronavirus virus 2 (SARS-CoV-2) PCR-negative patients spent in a high-risk area alongside SARS-CoV-2-positive patients.

Keyphrases

sars cov
coronavirus disease
emergency department
respiratory syndrome coronavirus
end stage renal disease
ejection fraction
newly diagnosed
peritoneal dialysis
case report